VANDERBILT UNIVERSITY MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1925-01-01

Employees: 10K

Market Cap: -

Website: http://www.vumc.org

Clinical Trials

Hemodialysis.-Induced Hypotension Therapy for End Stage Kidney Disease

Phase 2

Recruiting

Conditions: Hemodialysis Complication
Hypotension of Hemodialysis

Interventions: Drug: Lanadelumab Injection [Takhzyro]
Drug: Placebo

First Posted Date: 2022-03-28

Last Posted Date: 2024-10-26

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 32

Registration Number: NCT05297786

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Pragmatic Implementation of Mindful Awareness in Body Oriented Therapy

Completed

Conditions: Non-pharmacologic Management of Chronic Pain

Interventions: Behavioral: Mindful Awareness in Body-Oriented Therapy

First Posted Date: 2022-03-21

Last Posted Date: 2024-03-06

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 41

Registration Number: NCT05289024

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT

Phase 2

Recruiting

Conditions: Dysbiosis
Microtia
Alcohol Drinking
HIV Infections
Cardiovascular Diseases

Interventions: Dietary Supplement: Placebo
Dietary Supplement: Probiotic

First Posted Date: 2022-03-21

Last Posted Date: 2024-07-01

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 250

Registration Number: NCT05288790

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

nCCR for Chemotherapy Related Cognitive Impairment Randomized Study

Not Applicable

Recruiting

Conditions: Chemo-brain
Chemotherapy-Related Cognitive Impairment

Interventions: Behavioral: Neuroplasticity-based Computerized Cognitive Remediation
Behavioral: Education Control Condition

First Posted Date: 2022-03-17

Last Posted Date: 2024-06-21

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 20

Registration Number: NCT05283629

Locations: 🇺🇸
Center for Cognitive Medicine at Vanderbilt University, Nashville, Tennessee, United States

Randomized Trial of Sedative Choice for Intubation

Phase 4

Recruiting

Conditions: Acute Respiratory Failure

Interventions: Drug: Ketamine
Drug: Etomidate

First Posted Date: 2022-03-14

Last Posted Date: 2024-10-04

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 2364

Registration Number: NCT05277896

Locations: 🇺🇸
UAB Hospital, Birmingham, Alabama, United States
🇺🇸
University of Colorado Denver, Aurora, Colorado, United States
🇺🇸
Denver Health Medical Center, Denver, Colorado, United States

and more 3 locations

The Electronic Medical Records and GEnomics (eMERGE) Network Genomic Risk Assessment

Not Applicable

Active, not recruiting

Conditions: Genetic Disease

Interventions: Other: Genome Informed Risk Assessment (GIRA) report

First Posted Date: 2022-03-14

Last Posted Date: 2024-08-13

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 26877

Registration Number: NCT05277116

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Mountain Park Health Center, Tempe, Arizona, United States

and more 9 locations

2-HOBA Phase 2 Clinical Trial in Rheumatoid Arthritis

Phase 2

Recruiting

Conditions: Rheumatoid Arthritis

Interventions: Other: Placebo
Drug: 2-HOBA

First Posted Date: 2022-03-10

Last Posted Date: 2024-07-03

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 32

Registration Number: NCT05274243

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Pancreatic Enzyme Replacement and Glucose Regulation in Type 1 Diabetes

Early Phase 1

Completed

Conditions: Type 1 Diabetes

Interventions: Drug: Placebo
Drug: CREON

First Posted Date: 2022-03-04

Last Posted Date: 2024-10-02

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 10

Registration Number: NCT05266963

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

Pragmatic Trial Examining Oxygenation Prior to Intubation

Not Applicable

Completed

Conditions: Acute Respiratory Failure

Interventions: Other: Facemask Oxygen
Other: Preoxygenation with Non-Invasive Positive Pressure Ventilation

First Posted Date: 2022-03-04

Last Posted Date: 2024-12-09

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 1301

Registration Number: NCT05267652

Locations: 🇺🇸
University of Wisconsin-Madison, Madison, Wisconsin, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Hennepin County Medical Center, Minneapolis, Minnesota, United States

and more 13 locations

Glucagon-Like Peptide-1 Receptor Agonist in the Treatment of Adult, Obesity-related, Symptomatic Asthma (GATA-3)

Phase 2

Recruiting

Conditions: Asthma

Interventions: Other: Placebo
Drug: Semaglutide Pen Injector 2.4mg weekly

First Posted Date: 2022-02-24

Last Posted Date: 2024-08-14

Lead Sponsor: Vanderbilt University Medical Center

Target Recruit Count: 100

Registration Number: NCT05254314

Locations: 🇺🇸
Vanderbilt University Medical Center, Nashville, Tennessee, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy